Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe and the Americas, Asia, and Africa.
Over the past several years, we have embarked on a transformative journey to become a truly global innovative healthcare company with a leading focus on Gastrointestinal (GI) health. Through significant growth, strategic acquisitions, portfolio expansion, and increased investment in specialty and rare disease, we are building a stronger platform for long-term success.
But our journey is far from complete.
As we continue to grow, we are seeking a Director, HCP Marketing to join the LYNAVOY US Marketing Team. LYNAVOY is the first and only therapy specifically indicated for cholestatic pruritus in Primary Biliary Cholangitis (PBC), a rare liver disease.
Reporting to the Executive Director, HCP Marketing & Brand Strategy, this individual will be responsible for leading HCP marketing strategy, promotion, customer engagement, and omnichannel activation to drive brand growth, support appropriate patient identification, and improve customer engagement. This role will serve as a key commercial leader responsible for translating brand strategy into impactful HCP initiatives across personal and non-personal channels.
This is a hybrid position based out of our Morristown, NJ office.
This role is ideal for a strategic and execution-oriented marketer who thrives at the intersection of brand strategy, customer engagement, and commercial execution. The Director, HCP Marketing will be accountable for developing and executing HCP marketing strategies focused on HCP promotion, customer engagement, and omnichannel strategy for the LYNAVOY brand.
Reporting to Executive Director, HCP Marketing, this position will lead development of HCP promotional strategy, messaging, campaigns, field-facing resources, and tactical plans while partnering closely with Sales, Medical Affairs, Market Access, Commercial Operations, Analytics, and Training. In addition, the role will drive HCP omnichannel strategy, customer journey design, channel planning, and performance measurement to ensure an integrated and coordinated customer experience across all touchpoints.
Success in this role requires strong commercial acumen, customer-centric thinking, analytical rigor, cross-functional leadership, and the ability to convert insights into action that drives measurable business results.
This role works closely with teams responsible for Medical Education, Congress Strategy, Peer-to-Peer Programs, Speaker Bureau, Scientific Communications, and Medical Affairs initiatives.
While highly collaborative with these functions, ownership of these programs resides outside of this role. The Director, HCP Marketing is responsible for ensuring alignment between these activities and overall HCP brand strategy while maintaining primary ownership of HCP promotion, customer engagement, and omnichannel marketing.
At Alfasigma, we foster a culture where innovation, entrepreneurship, and collaboration drive our success.
We offer competitive compensation, comprehensive benefits, and opportunities for professional growth while giving employees the ability to make a meaningful impact on patients' lives.
Our commitment to people and patients is at the heart of everything we do. We value diverse perspectives, encourage bold thinking, and believe that our collective expertise enables us to create meaningful advancements in healthcare.
Join Alfasigma and become part of a forward-thinking team dedicated to shaping the future of the pharmaceutical industry.
The anticipated salary range for this position is $230,000-$260,000. Actual compensation will be determined based on experience, qualifications, geographic location, and business considerations.
The salary range listed is only one component of our total rewards package. Alfasigma US also provides a competitive suite of benefits, including:
Employment decisions at the Company are made without unlawful regard to race, color, religion, creed, national origin, alienage or citizenship status, sex (including gender, pregnancy, childbirth or related medical conditions), gender identity or expression, sexual orientation, ethnicity, age, physical or mental disability, legally protected genetic information, marital or partnership status, military or veteran status, reproductive health decisions, or any other status protected by applicable federal, state, or local law.
This organization participates in E-Verify.
Alfasigma is a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered (in Bologna and Milan).
The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT; Trezzano Rosa, MI), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo).
Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers.
It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals.
Read here our social media netiquette: https://it.alfasigma.com/informative-privacy/netiquettesocialnetwork/
